Staph aureus bacteremia: 2021 Management Updates

Presented by Thomas Holland, Dr. Thomas L. Holland, MD, MSc-GH, associate professor of infectious diseases at Duke University and a faculty member of the Duke Clinical Research Institute. His research interests include antibacterial trials, particularly for S. aureus bacteremia and antibiotic-resistant pathogens, as well as the design and implementation of novel clinical trial endpoints including ordinal outcomes and quality of life measures. He is active in COVID clinical care and research.